Longevity & Anti-Aging Medicine

Hormone Replacement Therapy (HRT)

HGH, Sermorelin, Testosterone and HCG Treatments

Personalized and Customized Medicine

Longevity Medicine

Merck grants license to LabCorp for development of genetic test to predict response of HCV patients

Published: 29 July 2010 - Written by admin in section: Gene therapy

Merck announced a non-exclusive license agreement with Laboratory Corporation of America Holdings (LabCorp) for the commercialization of a genetic test that may help predict the response of patients with Hepatitis C virus (HCV) infection to peginterferon alpha-based therapy.

«
»







Get our latest updates

Subscribe Via A Feed Reader

Recommended Resources:



Archives